Jump to content

News Forum - Thai FDA approve Novavax’s Covovax Covid-19 vaccine


Recommended Posts

Novavax’s protein-based Covovax vaccine for active immunisation against Covid-19 was approved for use by Thailand’s Food and Drug Administration, or FDA, on Friday. The FDA granted emergency use authorisation for the vaccine for individuals 18 years of age and older. The vaccine, known as NVX-CoV2373, is manufactured and marketed under the brand name Covovax. The FDA’s decision was based on the preclinical, manufacturing and clinical trial data submitted for review. US based biotechnology company Novavax have conducted two pivotal Phase 3 clinical trials: PREVENT-19 included 30,000 participants aged 18 years and older in the US and Mexico and was published […]

The story Thai FDA approve Novavax’s Covovax Covid-19 vaccine as seen on Thaiger News.

Read the full story

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Unfortunately, your content contains terms that we do not allow. Please edit your content to remove the highlighted words below.
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.


  • Create New...

Important Information

By posting on Thaiger Talk you agree to the Terms of Use